Home Newsfeeds Credit Suisse Initiates Coverage On Fulgent Genetics with Outperform Rating, Announces Price Target of $65

Credit Suisse Initiates Coverage On Fulgent Genetics with Outperform Rating, Announces Price Target of $65

Credit Suisse analyst Dan Leonard initiates coverage on Fulgent Genetics (NASDAQ:FLGT) with a Outperform rating and announces Price Target of $65.

byBenzinga Newsdesk

August 25, 2022

1 minute read

Credit Suisse analyst Dan Leonard initiates coverage on Fulgent Genetics (NASDAQ:FLGT) with a Outperform rating and announces Price Target of $65.

Shell’s Hydrogen Exit In California Deals A Major Blow To State’s Green Mobility Drive

By Benzinga Neuro

February 12, 7:12 AM

Shell's decision is a significant blow to the struggling hydrogen fuel cell passenger technology in California and the broader U.S. market.

SHEL

Agrify Announces Pricing Of Public Offering, Combined Public Offering Price For Each Share Of Common Stock And Accompanying Two Common Warrants Is $0.65

By Bill Haddad

December 16, 9:08 AM

BILLERICA, Mass., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Agrify Corporation (NASDAQ:AGFY) ("Agrify" or the "Company"), a leading provider of innovative cultivation and extraction solutions for the cannabis

AGFY

What’s Going On With Clover Health Stock Tuesday?

By Adam Eckert

November 7, 10:28 AM

Clover Health Investments Corp (NASDAQ: CLOV) shares are trading lower Tuesday on the heels of the company's third-quarter financial results.

CLOV

Analyst Ratings

Analyst Ratings for Navitas Semiconductor

By Benzinga Insights

September 7, 8:00 AM

Over the past 3 months, 8 analysts have published their opinion on Navitas Semiconductor (NASDAQ:NVTS) stock. These analysts…

NVTS

Credit Suisse Initiates Coverage On Fulgent Genetics with Outperform Rating, Announces Price Target of $65

Related Posts

Shell’s Hydrogen Exit In California Deals A Major Blow To State’s Green Mobility Drive

Agrify Announces Pricing Of Public Offering, Combined Public Offering Price For Each Share Of Common Stock And Accompanying Two Common Warrants Is $0.65

What’s Going On With Clover Health Stock Tuesday?

Analyst Ratings for Navitas Semiconductor